Business Description
GL Pharm Tech Corp
ISIN : KR7204840003
Compare
Compare
Traded in other countries / regions
204840.Korea IPO Date
2014-11-20Description
GL Pharm Tech Corp is engaged in developing and marketing pharmaceutical products. It offers products including Incrementally Modified Drugs, Generic Drug and G-SOREN Tab. It also provides generic drugs for cardiovascular, gastric, diabetes, CNS, and respiratory diseases.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.47 | |||||
| Equity-to-Asset | 0.48 | |||||
| Debt-to-Equity | 0.75 | |||||
| Debt-to-EBITDA | -16.68 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.95 | |||||
| Beneish M-Score | -2.62 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 15.9 | |||||
| 3-Year EBITDA Growth Rate | -2 | |||||
| 3-Year EPS without NRI Growth Rate | 11.8 | |||||
| 3-Year FCF Growth Rate | 6.2 | |||||
| 3-Year Book Growth Rate | -12.4 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.41 | |||||
| 9-Day RSI | 45.45 | |||||
| 14-Day RSI | 44.25 | |||||
| 6-1 Month Momentum % | -6.98 | |||||
| 12-1 Month Momentum % | -11.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.53 | |||||
| Quick Ratio | 0.85 | |||||
| Cash Ratio | 0.6 | |||||
| Days Inventory | 166.38 | |||||
| Days Sales Outstanding | 63.74 | |||||
| Days Payable | 54.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.7 | |||||
| Shareholder Yield % | -13.13 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 36.77 | |||||
| Operating Margin % | -10.16 | |||||
| Net Margin % | -13.73 | |||||
| FCF Margin % | -18.65 | |||||
| ROE % | -20.05 | |||||
| ROA % | -8.06 | |||||
| ROIC % | -7.26 | |||||
| ROC (Joel Greenblatt) % | -10.65 | |||||
| ROCE % | -9.29 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.6 | |||||
| PB Ratio | 3.86 | |||||
| Price-to-Tangible-Book | 4.08 | |||||
| EV-to-EBIT | -31.46 | |||||
| EV-to-EBITDA | -94.91 | |||||
| EV-to-Revenue | 3.35 | |||||
| EV-to-FCF | -17.96 | |||||
| Earnings Yield (Greenblatt) % | -3.18 | |||||
| FCF Yield % | -6.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GL Pharm Tech Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 24,900.201 | ||
| EPS (TTM) (â‚©) | -51 | ||
| Beta | 0.79 | ||
| Volatility % | 46.8 | ||
| 14-Day RSI | 44.25 | ||
| 14-Day ATR (â‚©) | 44.183679 | ||
| 20-Day SMA (â‚©) | 999.75 | ||
| 12-1 Month Momentum % | -11.66 | ||
| 52-Week Range (â‚©) | 944 - 1540 | ||
| Shares Outstanding (Mil) | 76.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GL Pharm Tech Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GL Pharm Tech Corp Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
GL Pharm Tech Corp Frequently Asked Questions
What is GL Pharm Tech Corp(XKRX:204840)'s stock price today?
The current price of XKRX:204840 is â‚©984.00. The 52 week high of XKRX:204840 is â‚©1540.00 and 52 week low is â‚©944.00.
When is next earnings date of GL Pharm Tech Corp(XKRX:204840)?
The next earnings date of GL Pharm Tech Corp(XKRX:204840) is .
Does GL Pharm Tech Corp(XKRX:204840) pay dividends? If so, how much?
GL Pharm Tech Corp(XKRX:204840) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers